Lucie Abeler-Dörner1, Mary K Grabowski2, Andrew Rambaut3, Deenan Pillay4,5, Christophe Fraser1. 1. Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Rakai Health Sciences Program, Baltimore, USA. 3. Institute of Evolutionary Biology, University of Edinburgh, Ashworth Laboratories, Edinburgh, UK. 4. Africa Health Research Institute, KwaZulu-Natal, South Africa. 5. Division of Infection and Immunity, University College London, London, UK.
Abstract
PURPOSE OF REVIEW: The HIV epidemic in sub-Saharan Africa is far from being under control and the ambitious UNAIDS targets are unlikely to be met by 2020 as declines in per-capita incidence being largely offset by demographic trends. There is an increasing number of proven and specific HIV prevention tools, but little consensus on how best to deploy them. RECENT FINDINGS: Traditionally, phylogenetics has been used in HIV research to reconstruct the history of the epidemic and date zoonotic infections, whereas more recent publications focus on HIV diversity and drug resistance. However, it is also the most powerful method of source attribution available for the study of HIV transmission. The PANGEA (Phylogenetics And Networks for Generalized Epidemics in Africa) consortium has generated over 18 000 NGS HIV sequences from five countries in sub-Saharan Africa. Using phylogenetic methods, we will identify characteristics of individuals or groups, which are most likely to be at risk of infection or at risk of infecting others. SUMMARY: Combining phylogenetics, phylodynamics and epidemiology will allow PANGEA to highlight where prevention efforts should be focussed to reduce the HIV epidemic most effectively. To maximise the public health benefit of the data, PANGEA offers accreditation to external researchers, allowing them to access the data and join the consortium. We also welcome submissions of other HIV sequences from sub-Saharan Africa to the database.
PURPOSE OF REVIEW: The HIV epidemic in sub-Saharan Africa is far from being under control and the ambitious UNAIDS targets are unlikely to be met by 2020 as declines in per-capita incidence being largely offset by demographic trends. There is an increasing number of proven and specific HIV prevention tools, but little consensus on how best to deploy them. RECENT FINDINGS: Traditionally, phylogenetics has been used in HIV research to reconstruct the history of the epidemic and date zoonotic infections, whereas more recent publications focus on HIV diversity and drug resistance. However, it is also the most powerful method of source attribution available for the study of HIV transmission. The PANGEA (Phylogenetics And Networks for Generalized Epidemics in Africa) consortium has generated over 18 000 NGS HIV sequences from five countries in sub-Saharan Africa. Using phylogenetic methods, we will identify characteristics of individuals or groups, which are most likely to be at risk of infection or at risk of infecting others. SUMMARY: Combining phylogenetics, phylodynamics and epidemiology will allow PANGEA to highlight where prevention efforts should be focussed to reduce the HIV epidemic most effectively. To maximise the public health benefit of the data, PANGEA offers accreditation to external researchers, allowing them to access the data and join the consortium. We also welcome submissions of other HIV sequences from sub-Saharan Africa to the database.
Authors: Alexandra M Oster; Christina G Dorell; Leandro A Mena; Peter E Thomas; Carlos A Toledo; James D Heffelfinger Journal: Am J Public Health Date: 2010-11-18 Impact factor: 9.308
Authors: Veena G Billioux; Larry W Chang; Steven J Reynolds; Gertrude Nakigozi; Joseph Ssekasanvu; Mary K Grabowski; Robert Ssekubugu; Fred Nalugoda; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Ronald H Gray; Maria J Wawer Journal: J Int AIDS Soc Date: 2017-06-05 Impact factor: 5.396
Authors: Mary A Rodgers; Eduan Wilkinson; Ana Vallari; Carole McArthur; Larry Sthreshley; Catherine A Brennan; Gavin Cloherty; Tulio de Oliveira Journal: J Virol Date: 2017-02-28 Impact factor: 5.103
Authors: Vladimir Novitsky; Hermann Bussmann; Andrew Logan; Sikhulile Moyo; Erik van Widenfelt; Lillian Okui; Mompati Mmalane; Jeannie Baca; Lauren Buck; Eleanor Phillips; David Tim; Mary Fran McLane; Quanhong Lei; Rui Wang; Joseph Makhema; Shahin Lockman; Victor DeGruttola; M Essex Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240
Authors: George M Nduva; Frederick Otieno; Joshua Kimani; Elizabeth Wahome; Lyle R McKinnon; Francois Cholette; Maxwell Majiwa; Moses Masika; Gaudensia Mutua; Omu Anzala; Susan M Graham; Larry Gelmon; Matt A Price; Adrian D Smith; Robert C Bailey; Guy Baele; Philippe Lemey; Amin S Hassan; Eduard J Sanders; Joakim Esbjörnsson Journal: Virus Evol Date: 2022-03-03